COSCIENS Biopharma Inc. Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities of $6.00 thousand for the 3-month period ending 2024-03-31, per its 6-K filed 2024-05-16.
Discontinued › Cash Flow
ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities · last filed 2024-07-17
- COSCIENS Biopharma Inc. increase decrease through effect of changes in foreign exchange rates liabilities arising from financing activities for the quarter ending 2024-03-31 was $6.00K.
- COSCIENS Biopharma Inc. increase decrease through effect of changes in foreign exchange rates liabilities arising from financing activities for the quarter ending 2023-09-30 was -$3.00K.
- COSCIENS Biopharma Inc. increase decrease through effect of changes in foreign exchange rates liabilities arising from financing activities for the quarter ending 2023-06-30 was -$9.00K.
- COSCIENS Biopharma Inc. increase decrease through effect of changes in foreign exchange rates liabilities arising from financing activities for the quarter ending 2023-03-31 was -$8.00K.
| Period end | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 3 month | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 3 month as first filed | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 6 month | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 9 month | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 12 month | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $6.00K 6-K · filed 2024-05-16 | |||||
| 2023-12-31 | $7.00K 20-F/A · filed 2024-07-17 | |||||
| 2023-09-30 | -$3.00K 6-K · filed 2023-11-09 | -$4.00K 6-K · filed 2023-11-09 | ||||
| 2023-06-30 | -$9.00K 6-K · filed 2023-08-09 | -$1.00K 6-K · filed 2023-08-09 | ||||
| 2023-03-31 | -$8.00K 6-K · filed 2024-05-16 | $8.00K 6-K · filed 2023-05-09 | ||||
| 2022-12-31 | -$16.00K 20-F/A · filed 2024-07-17 | $16.00K 20-F · filed 2023-03-23 | ||||
| 2022-06-30 | -$513.00K 6-K · filed 2023-08-09 | -$687.00K 6-K · filed 2023-08-09 | ||||
| 2022-03-31 | -$174.00K 6-K · filed 2023-05-09 | |||||
| 2021-12-31 | $179.00K 20-F/A · filed 2024-07-17 | -$179.00K 20-F · filed 2023-03-23 | ||||
| 2020-12-31 | -$688.00K 20-F/A · filed 2024-02-15 |